TH153704A - Pharmaceutical components for topical use - Google Patents
Pharmaceutical components for topical useInfo
- Publication number
- TH153704A TH153704A TH1201006090A TH1201006090A TH153704A TH 153704 A TH153704 A TH 153704A TH 1201006090 A TH1201006090 A TH 1201006090A TH 1201006090 A TH1201006090 A TH 1201006090A TH 153704 A TH153704 A TH 153704A
- Authority
- TH
- Thailand
- Prior art keywords
- weight
- topical use
- pharmaceutical components
- skin
- momethazone
- Prior art date
Links
- 230000000699 topical Effects 0.000 title claims abstract 3
- 239000005426 pharmaceutical component Substances 0.000 title claims 2
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-Furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 claims abstract 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-Methyl-2,4-pentanediol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims abstract 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims abstract 2
- 210000003491 Skin Anatomy 0.000 claims abstract 2
- 208000006641 Skin Disease Diseases 0.000 claims abstract 2
- 201000008937 atopic dermatitis Diseases 0.000 claims abstract 2
- 201000004624 dermatitis Diseases 0.000 claims abstract 2
- 231100000406 dermatitis Toxicity 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 229940051250 hexylene glycol Drugs 0.000 claims abstract 2
- 201000004681 psoriasis Diseases 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000000470 constituent Substances 0.000 abstract 1
Abstract
DC60 (23/11/55) อธิบายองค์ประกอบทางเภสัชกรรมสำหรับใช้เฉพาะที่ ซึ่งประกอบรวมด้วย พื้นฐานมาจาก น้ำหนักรวมขององค์ประกอบ a) โมเมแทโซน ฟูโรเอท 0.01 ถึง 0.2% โดยน้ำหนัก b) เฮกซิลีน ไกลคอล 5 ถึง 18 % โดยน้ำหนัก c) น้ำ 20 ถึง 40% โดยน้ำหนัก, และ d) วัฏภาคน้ำมัน 25 ถึง 70% โดยน้ำหนัก องค์ประกอบดังกล่าวมีความเสถียร และสามารถใช้บนพื้นที่ผิวหนังขนาดใหญ่ได้อย่างปลอดภัย และ ง่ายดาย ในวิถีทางซึ่งเป็นที่ยอมรับโดยประชากรคนไข้ทั่วไปสำหรับการรักษา หรือป้องกันโรคสะเก็ด เงิน, โรคผื่นภูมิแพ้ผิวหนัง (อะโทพิค เอคซีม (atopic eczema)) และอาการผิดปกติทางผิวหนัง หรือ โรคผิวหนัง : สิทธิบัตรยา DC60 (11/11/2012) describes the pharmaceutical constituents for topical use. This includes the basis from the total weight of the elements a) Momethazone Furoate 0.01 to 0.2% by weight b) hexylene glycol 5 to 18% by weight c) 20 to 40% water Weight, and d). The oil cycle is 25 to 70% by weight. And can be safely and easily applied over large areas of the skin in a way accepted by the general patient population for treatment. Or prevent psoriasis, atopic eczema and skin disorders or dermatitis: patent drug.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH153704A true TH153704A (en) | 2016-06-30 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT201300243A (en) | RAMIFIED 3-PHENYLPROPIONIC ACID DERIVATIVES AND ITS USE | |
| CO6571913A2 (en) | Derivatives of fatty acid fumarate and its uses | |
| ECSP12012310A (en) | 5-FLUORO-1H-REPLACED PIRAZOLOPIRIDINES AND ITS USE | |
| UY32497A (en) | "2-ACETAMIDO-5-ARIL-1,2,4-SUBSTITUTED TRIAZOLONS AND THEIR USE" | |
| BR112015019657A2 (en) | topical compositions and methods of use thereof | |
| GT201200250A (en) | ARILTRIAZOLONAS LINKED TO BISARILO AND ITS USE | |
| WO2014049447A3 (en) | A whole, leech saliva extract | |
| DOP2013000130A (en) | PIRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS THROUGH LP - PLA2 | |
| ITTO20110627A1 (en) | PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS TO TREAT DIABETES AND METABOLIC DISORDERS | |
| MX2012013642A (en) | Topical pharmaceutical compositions comprising mometasone furoate. | |
| RS54131B1 (en) | New pharmaceutical composition for the treatment of fungal infections | |
| CL2014003325A1 (en) | Compounds derived from difluoro-hexahydro-cyclopentaoxacinyls and difluoro-hexahydro-benzooxacinyls, bace 1 inhibitors; pharmaceutical composition; and its use in the treatment of diseases with elevated levels of beta-amyloid, such as Alzheimer's disease | |
| DOP2016000076A (en) | TIENOURACILCARBOXAMIDAS AND USES OF THE SAME | |
| BR112015029619A2 (en) | 1,3-diaminocyclopentane carboxamide derivatives | |
| BR112015001627A2 (en) | pharmaceutical composition, their uses and method of decreasing the frequency of urination | |
| TH153704A (en) | Pharmaceutical components for topical use | |
| UA112981C2 (en) | OPTION OF HUMAN GDNF | |
| EA201401142A1 (en) | SUBSTITUTED 6-AMINONICOTINAMIDES, BEARING IT-CONTAINING GROUP, AS KCNQ2 / 3 MODULATORS | |
| UA111785C2 (en) | A COMPOSITION FOR THE TREATMENT OF Warts And A WAY OF TREATMENT | |
| FR2980975B1 (en) | NOVEL DERMATOLOGICAL COMPOSITION COMPRISING TOCOPHEROL, AN OILY MACERATE OF CALENDULA FLOWERS IN ROSE MUSKY OIL, RETINOL PALMITATE AND UBIQUINONE | |
| TH136241A (en) | Components for treatment and / or prevention of skin disorders. | |
| TH156803A (en) | Composition for applying the skin and its use | |
| TH132750A (en) | Oral care composition | |
| TH152490A (en) | Regulators of estrogen receptors and their use | |
| TH1401001585A (en) | Composition for peeling the skin and the use of such compositions. |